Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-23T17:03:21.769Z Has data issue: false hasContentIssue false
  • English
  • Français

THYROTOXICOSIS IN PREGNANCY

Published online by Cambridge University Press:  09 August 2013

H V WRIGHT  and
D J WILLIAMS
H V WRIGHT*
Affiliation:
University College London Hospitals, London, UK.
D J WILLIAMS
Affiliation:
University College London Hospital, Institute for Women's Health, London, UK.
*
H V Wright, University College London Hospitals, London, UK. Email: hannahwright5@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Extract

Thyrotoxicosis affects approximately 1:500 women of reproductive age. Untreated or poorly controlled thyrotoxicosis in pregnancy is associated with significant maternal and perinatal morbidity. Recognition and diagnosis of new onset thyrotoxicosis in pregnancy can be challenging as many of the symptoms can be misattributed to physiological adaptation of normal pregnancy. Women with hyperemesis gravidarum (HG) often have biochemical, but not clinical evidence of thyrotoxicosis, which does not need treatment with anti-thyroid drugs (ATDs). For women with clinical thyrotoxicosis, uncertainty regarding the risks of teratogenicity due to ATDs has led to new guideline recommendations for their use in pregnancy. Women with autoimmune diseases such as type I diabetes and who have thyroid peroxidase antibodies (TPOAb) are at an increased risk of developing postpartum thyroiditis, which can result in permanent hypothyroidism. This review summarises the management of thyrotoxicosis in pregnancy and highlights controversial areas for which conclusive evidence is still lacking.

Type
Review Article
Information
Fetal and Maternal Medicine Review , Volume 24 , Issue 2 , May 2013 , pp. 108 - 128
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1Glinoer, D, De, NP, Robyn, C, Lejeune, B, Kinthaert, J, Meuris, S. Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 1993 Dec 16 (11): 881–8.CrossRefGoogle ScholarPubMed
2Fantz, CR, Dagogo-Jack, S, Ladenson, JH, Gronowski, AM. Thyroid function during pregnancy. Clin Chem 1999 Dec 45 (12): 2250–58.CrossRefGoogle ScholarPubMed
3De, GL, Abalovich, M, Alexander, EK, Amino, N, Barbour, L, Cobin, RH, et al.Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012 Aug 97 (8): 2543–65.Google Scholar
4Nor Azlin, MI, Bakin, YD, Mustafa, N, Wahab, NA, Johari, MJ, Kamarudin, NA, et al.Thyroid autoantibodies and associated complications during pregnancy. J Obstet Gynaecol 2010 30 (7): 675–8.CrossRefGoogle ScholarPubMed
5Negro, R, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Stagnaro-Green, A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab 2010 Apr 95 (4): 1699–707.CrossRefGoogle ScholarPubMed
6Glinoer, D. The systematic screening and management of hypothyroidism and hyperthyroidism during pregnancy. Trends Endocrinol Metab 1998 Dec 9 (10): 403–11.CrossRefGoogle ScholarPubMed
7Tan, JY, Loh, KC, Yeo, GS, Chee, YC. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002 Jun 109 (6): 683–8.CrossRefGoogle ScholarPubMed
8Yeo, CP, Khoo, DH, Eng, PH, Tan, HK, Yo, SL, Jacob, E. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin. Clin Endocrinol (Oxf) 2001 Sep 55 (3): 391–8.CrossRefGoogle ScholarPubMed
9Jorgensen, KT, Nielsen, NM, Pedersen, BV, Jacobsen, S, Frisch, M. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun 2012 May 38(2–3): J120–28.Google Scholar
10Casey, BM, Dashe, JS, Wells, CE, McIntire, DD, Leveno, KJ, Cunningham, FG. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006 Feb 107 (2 Pt 1): 337–41.CrossRefGoogle ScholarPubMed
11Su, PY, Huang, K, Hao, JH, Xu, YQ, Yan, SQ, Li, T, et al.Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011 Oct 96 (10): 3234–41.CrossRefGoogle ScholarPubMed
12Negro, R, Mestman, JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab 2011 Dec 25 (6): 927–43.CrossRefGoogle ScholarPubMed
13Mitsuda, N, Tamaki, H, Amino, N, Hosono, T, Miyai, K, Tanizawa, O. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol 1992 Sep 80 (3 Pt 1): 359–64.Google ScholarPubMed
14Rasmussen, SA, Yazdy, MM, Carmichael, SL, Jamieson, DJ, Canfield, MA, Honein, MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 2007 Aug 110 (2 Pt 1): 369–77.CrossRefGoogle ScholarPubMed
15Rotondi, M, Cappelli, C, Pirali, B, Pirola, I, Magri, F, Fonte, R, et al.The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008 Oct 93 (10): 3985–8.CrossRefGoogle ScholarPubMed
16Benhaim, RD, Davies, TF. Increased risk of Graves’ disease after pregnancy. Thyroid 2005 Nov 15 (11): 1287–90.Google Scholar
17Rotondi, M, Pirali, B, Lodigiani, S, Bray, S, Leporati, P, Chytiris, S, et al.The post partum period and the onset of Graves’ disease: an overestimated risk factor. Eur J Endocrinol 2008 Aug 159 (2): 161–5.CrossRefGoogle ScholarPubMed
18Nagasaki, T, Inaba, M, Fujiwara-Ueda, M, Nishio, J, Kumeda, Y, Hiura, Y, et al.Thyroid blood flow as a useful predictor of relapse of Graves’ disease after normal delivery in patients with Graves’ disease. Biomed Pharmacother 2010 Feb 64 (2): 113–7.CrossRefGoogle ScholarPubMed
19Hamada, N, Momotani, N, Ishikawa, N, Yoshimura, NJ, Okamoto, Y, Konishi, T, et al.Persistent high TRAb values during pregnancy predict increased risk of neonatal hyperthyroidism following radioiodine therapy for refractory hyperthyroidism. Endocr J 2011 58 (1): 55–8.CrossRefGoogle ScholarPubMed
20Cooper, DS. Antithyroid drugs. N Engl J Med 2005 Mar 3 352 (9): 905–17.CrossRefGoogle ScholarPubMed
21Mortimer, RH, Cannell, GR, Addison, RS, Johnson, LP, Roberts, MS, Bernus, I. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997 Sep 82 (9): 3099–102.Google ScholarPubMed
22Momotani, N, Noh, JY, Ishikawa, N, Ito, K. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 1997 Nov 82 (11): 3633–36.Google ScholarPubMed
23Ferraris, S, Valenzise, M, Lerone, M, Divizia, MT, Rosaia, L, Blaid, D, et al.Malformations following methimazole exposure in utero: an open issue. Birth Defects Res A Clin Mol Teratol 2003 Dec 67 (12): 989–92.CrossRefGoogle ScholarPubMed
24Guignon, AM, Mallaret, MP, Jouk, PS. Carbimazole-related gastroschisis. Ann Pharmacother 2003 Jun 37 (6): 829–31.CrossRefGoogle ScholarPubMed
25Rodriguez-Garcia, C, Gonzalez-Hernandez, S, Hernandez-Martin, A, Perez-Robayna, N, Sanchez, R, Torrelo, A. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy. Pediatr Dermatol 2011 Nov 28 (6): 743–5.CrossRefGoogle ScholarPubMed
26Yoshihara, A, Noh, J, Yamaguchi, T, Ohye, H, Sato, S, Sekiya, K, et al.Treatment of Graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012 Jul 97 (7): 2396–403.CrossRefGoogle ScholarPubMed
27Bowman, P, Osborne, NJ, Sturley, R, Vaidya, B. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. QJM 2012 Feb 105 (2): 189–93.CrossRefGoogle ScholarPubMed
28Singh, S, Pandey, A, Ahmed, I, Rawat, JD, Sharma, A, Srivastava, NK. Prolapse of bowel via patent vitello intestinal duct–a rare occurrence. Hernia 2011 Oct 15 (5): 567–9.CrossRefGoogle ScholarPubMed
29Rivkees, SA, Mandel, SJ. Thyroid disease in pregnancy. Horm Res Paediatr 2011 76(Suppl 1): 91–6.CrossRefGoogle ScholarPubMed
30Benavides, VC, Mallela, MK, Booth, CJ, Wendler, CC, Rivkees, SA. Propylthiouracil is teratogenic in murine embryos. PLoS One 2012 7 (4): e35213.CrossRefGoogle ScholarPubMed
31Di, GE, Schaefer, C, Mastroiacovo, PP, Cournot, MP, Benedicenti, F, Reuvers, M, et al.Adverse effects of prenatal methimazole exposure. Teratology 2001 Nov 64 (5): 262–6.Google Scholar
32Kuy, S, Roman, SA, Desai, R, Sosa, JA. Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009 May 144 (5): 399–406.CrossRefGoogle ScholarPubMed
33Lowe, SA. Diagnostic radiography in pregnancy: risks and reality. Aust N Z J Obstet Gynaecol 2004 Jun 44 (3): 191–6.CrossRefGoogle Scholar
34Laurberg, P, Nygaard, B, Glinoer, D, Grussendorf, M, Orgiazzi, J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998 Dec 139 (6): 584–6.CrossRefGoogle ScholarPubMed
35Friedland, DR, Rothschild, MA. Rapid resolution of fetal goiter associated with maternal Grave's disease: a case report. Int J Pediatr Otorhinolaryngol 2000 Aug 11 54 (1): 59–62.CrossRefGoogle ScholarPubMed
36Momotani, N, Ito, K, Hamada, N, Ban, Y, Nishikawa, Y, Mimura, T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 1984 Jun 20 (6): 695–700.CrossRefGoogle ScholarPubMed
37Laurberg, P, Bournaud, C, Karmisholt, J, Orgiazzi, J. Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009 Jan 160 (1): 1–8.CrossRefGoogle ScholarPubMed
38Kempers, MJ, van Tijn, DA, van Trotsenburg, AS, de Vijlder, JJ, Wiedijk, BM, Vulsma, T. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 2003 Dec 88 (12): 5851–7.CrossRefGoogle ScholarPubMed
39Amino, N, Miyai, K, Onishi, T, Hashimoto, T, Arai, K. Transient hypothyroidism after delivery in autoimmune thyroiditis. J Clin Endocrinol Metab 1976 Feb 42 (2): 296–301.CrossRefGoogle ScholarPubMed
40Negro, R, Greco, G, Mangieri, T, Pezzarossa, A, Dazzi, D, Hassan, H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007 Apr 92 (4): 1263–8.CrossRefGoogle ScholarPubMed
41Jaen Diaz, JI, Lopez De, CF, Cordero, GB, Santillana, BF, Sastre, MJ, Martin Dal, GC. Incidence of postpartum thyroiditis and study of possible associated factors. Med Clin (Barc) 2009 Apr 25 132 (15): 569–73.Google Scholar
42Alvarez-Marfany, M, Roman, SH, Drexler, AJ, Robertson, C, Stagnaro-Green, A. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994 Jul 79 (1): 10–6.Google ScholarPubMed
43Galanti, MR, Cnattingius, S, Granath, F, Ekbom-Schnell, A, Ekbom, A. Smoking and environmental iodine as risk factors for thyroiditis among parous women. Eur J Epidemiol 2007 22 (7): 467–72.CrossRefGoogle ScholarPubMed
44Belin, RM, Astor, BC, Powe, NR, Ladenson, PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2004 Dec 89 (12): 6077–86.CrossRefGoogle Scholar
45Nohr, SB, Jorgensen, A, Pedersen, KM, Laurberg, P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrinol Metab 2000 Sep 85 (9): 3191–8.CrossRefGoogle Scholar
46Manetti, L, Parkes, AB, Lupi, I, Di, CG, Bogazzi, F, Albertini, S, et al.Serum pituitary antibodies in normal pregnancy and in patients with postpartum thyroiditis: a nested case-control study. Eur J Endocrinol 2008 Dec 159 (6): 805–9.CrossRefGoogle ScholarPubMed
47Stuckey, BG, Kent, GN, Allen, JR, Ward, LC, Brown, SJ, Walsh, JP. Low urinary iodine postpartum is associated with hypothyroid postpartum thyroid dysfunction and predicts long-term hypothyroidism. Clin Endocrinol (Oxf) 2011 May 74 (5): 631–5.CrossRefGoogle ScholarPubMed
48Stagnaro-Green, A, Schwartz, A, Gismondi, R, Tinelli, A, Mangieri, T, Negro, R. High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab 2011 Mar 96 (3): 652–7.CrossRefGoogle Scholar
49Kent, GN, Stuckey, BG, Allen, JR, Lambert, T, Gee, V. Postpartum thyroid dysfunction: clinical assessment and relationship to psychiatric affective morbidity. Clin Endocrinol (Oxf) 1999 Oct 51 (4): 429–38.CrossRefGoogle ScholarPubMed
50Harris, B, Othman, S, Davies, JA, Weppner, GJ, Richards, CJ, Newcombe, RG, et al.Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992 Jul 18 305 (6846): 152–6.CrossRefGoogle Scholar
51Cotzias, C, Wong, SJ, Taylor, E, Seed, P, Girling, J. A study to establish gestation-specific reference intervals for thyroid function tests in normal singleton pregnancy. Eur J Obstet Gynecol Reprod Biol 2008 Mar 137 (1): 61–6.CrossRefGoogle ScholarPubMed